Canary Capital has registered a statutory trust in Delaware for its proposed Staked Injective (INJ) ETF. This marks a significant step toward the firm’s goal of launching a U.S.-based exchange-traded fund that will track Injective’s price while incorporating staking rewards.
Read the full article here
